ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

19,757Medicare Part D Prescriptions Filled, Including Refills

Rank: 16 out of 252

$885K Total Retail Price of All Prescriptions

Rank: 21 out of 252

625 Patients Receiving at Least One Drug in Part D
73%Patients 65 Years and Older
58% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Arkansas
Lower avg

Schedule Two
Controlled Substances

7% of this provider’s 625 patients filled at least one prescription for a schedule two drug, compared to an average of 5%.

Schedule Three
Controlled Substances

27% of this provider’s 625 patients filled at least one prescription for a schedule three drug, compared to an average of 15%.

Risky Drugs to Seniors

1% of this provider’s 14,013 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

19% of this provider’s prescriptions were for brand-name drugs, compared to an average of 23%.

Prescription Price

$45 was the average price of a prescription from this provider, compared to $53 among peers.

Prescriptions per Patient

32 is the average number of prescriptions (including refills) per patient, compared to an average of 22.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Arkansas
HYDROCODONE-ACETAMINOPHEN 859 454 S3 1 5
SIMVASTATIN 846 694 2 2
LISINOPRIL 613 498 3 3
FUROSEMIDE 517 384 4 7
POTASSIUM CHLORIDE 515 403 5 8
OMEPRAZOLE 473 359 6 6
GABAPENTIN 450 268 7 11
METFORMIN HCL 426 349 8 9
AMLODIPINE BESYLATE 403 307 9 4
HYDROCHLOROTHIAZIDE 367 270 10 13
METOPROLOL TARTRATE 363 283 11 10
LEVOTHYROXINE SODIUM 355 254 12 1
WARFARIN SODIUM 331 311 13 14
LISINOPRIL-HYDROCHLOROTHIAZIDE 287 206 14 25
ATENOLOL 286 210 15 18
DOXAZOSIN MESYLATE 277 207 16 73
METOPROLOL SUCCINATE 263 207 17 19
RANITIDINE HCL 261 187 18 48
MELOXICAM 259 177 19 20
CITALOPRAM HBR 258 199 20 15
SERTRALINE HCL 243 160 21 27
ATORVASTATIN CALCIUM 240 176 22 16
DONEPEZIL HCL 238 236 23 28
CLOPIDOGREL 234 175 24 29
ALENDRONATE SODIUM 223 206 25 32
GLIMEPIRIDE 208 158 26 40
TAMSULOSIN HCL 207 158 27 26
PRAVASTATIN SODIUM 187 154 28 12
TRAZODONE HCL 183 125 29 31
ZOLPIDEM TARTRATE 178 107 30 21
ISOSORBIDE MONONITRATE ER 176 121 31 50
NAMENDA 174 172 32 41
PLAVIX 173 132 33 43
CLONIDINE HCL 166 118 34 35
FLUTICASONE PROPIONATE 166 114 34 36
TRAMADOL HCL 153 103 36 17
ROPINIROLE HCL 151 118 37 84
ALLOPURINOL 130 104 38 30
AMITRIPTYLINE HCL 128 55 R 39 46
CRESTOR 124 78 40 34
CARVEDILOL 124 88 40 22
LOSARTAN POTASSIUM 119 91 42 24
CYMBALTA 118 72 43 45
NEXIUM 117 68 44 23
POLYETHYLENE GLYCOL 3350 115 95 45 67
CYCLOBENZAPRINE HCL 114 41 R 46 51
ENDOCET 111 48 S2 47 255
PREDNISONE 110 74 48 42
DOXYCYCLINE HYCLATE 107 65 49 92
SPIRIVA 103 59 50 68
RISPERIDONE 99 90 51 81
LOSARTAN-HYDROCHLOROTHIAZIDE 93 72 52 49
MIRTAZAPINE 92 88 53 58
RAMIPRIL 85 31 54 71
NOVOLOG FLEXPEN 84 57 55 195
AMLODIPINE BESYLATE-BENAZEPRIL 84 72 55 60
LEVEMIR FLEXPEN 84 48 55 199
LYRICA 81 33 58 66
NAPROXEN 78 51 59 96
PANTOPRAZOLE SODIUM 78 50 59 62
LANTUS SOLOSTAR 75 25 61 109
PROAIR HFA 75 37 61 54
SYMBICORT 74 52 63 137
QUETIAPINE FUMARATE 73 52 64 77
FENOFIBRATE 72 59 65 64
SINGULAIR 72 37 65 100
AMOX TR-POTASSIUM CLAVULANATE 72 43 65 132
SULFAMETHOXAZOLE-TRIMETHOPRIM 68 52 68 87
ZETIA 67 34 69 97
DIOVAN 65 60 70 38
KLOR-CON M20 64 43 71 69
FENTANYL 62 37 S2 72 126
ESCITALOPRAM OXALATE 62 28 72 56
TRIAMTERENE-HCTZ 61 50 74 33
CARBIDOPA-LEVODOPA 61 61 74 107
PREMARIN 60 15 R 76 116
ATENOLOL-CHLORTHALIDONE 59 20 77 148
AVODART 58 46 78 187
DIGOXIN 57 47 79 44
LEVEMIR 57 46 79 180
GEMFIBROZIL 56 46 81 98
LACTULOSE 56 32 81 157
SUCRALFATE 56 36 81 125
MECLIZINE HCL 55 50 84 136
VERAPAMIL ER 52 40 85 83
HYDRALAZINE HCL 52 35 85 95
DOXEPIN HCL 51 48 87 179
PAROXETINE HCL 51 33 87 75
NOVOLOG MIX 70-30 FLEXPEN 51 20 87 351
MUPIROCIN 50 37 90 213
DILTIAZEM ER 50 45 90 86
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Aug. 19, 2009.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.